Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10094818rdf:typepubmed:Citationlld:pubmed
pubmed-article:10094818lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:10094818lifeskim:mentionsumls-concept:C1516334lld:lifeskim
pubmed-article:10094818lifeskim:mentionsumls-concept:C0080113lld:lifeskim
pubmed-article:10094818lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:10094818pubmed:issue1lld:pubmed
pubmed-article:10094818pubmed:dateCreated1999-6-3lld:pubmed
pubmed-article:10094818pubmed:abstractTextDifferential phosphorylation of the retinoblastoma protein plays a pivotal role in cell cycle regulation. The retinoblastoma protein is specifically phosphorylated during the cell cycle by cyclin-dependent kinase complexes which intersect with many cellular signaling networks. Since the loss of the retinoblastoma signaling pathways occurs in a wide variety of human tumors, understanding the significance of site-specific phosphorylation can clarify the role of selected cyclin-dependent kinase complexes during cell cycle progression. Here we describe the phosphospecificity and cellular characterization of a panel of polyclonal antibodies that recognize unique phosphorylation sites within the retinoblastoma protein. These reagents were used to validate authentic cellular retinoblastoma phosphorylation sites at amino acids 780, 795, and 807/811 correlating with the G1-S transition.lld:pubmed
pubmed-article:10094818pubmed:languageenglld:pubmed
pubmed-article:10094818pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10094818pubmed:citationSubsetIMlld:pubmed
pubmed-article:10094818pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10094818pubmed:statusMEDLINElld:pubmed
pubmed-article:10094818pubmed:monthAprlld:pubmed
pubmed-article:10094818pubmed:issn0014-4827lld:pubmed
pubmed-article:10094818pubmed:authorpubmed-author:SharpD MDMlld:pubmed
pubmed-article:10094818pubmed:authorpubmed-author:PaiRRlld:pubmed
pubmed-article:10094818pubmed:authorpubmed-author:BoylanJ FJFlld:pubmed
pubmed-article:10094818pubmed:authorpubmed-author:BowersAAlld:pubmed
pubmed-article:10094818pubmed:authorpubmed-author:LeffelDDlld:pubmed
pubmed-article:10094818pubmed:copyrightInfoCopyright 1999 Academic Press.lld:pubmed
pubmed-article:10094818pubmed:issnTypePrintlld:pubmed
pubmed-article:10094818pubmed:day10lld:pubmed
pubmed-article:10094818pubmed:volume248lld:pubmed
pubmed-article:10094818pubmed:ownerNLMlld:pubmed
pubmed-article:10094818pubmed:authorsCompleteYlld:pubmed
pubmed-article:10094818pubmed:pagination110-4lld:pubmed
pubmed-article:10094818pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10094818pubmed:meshHeadingpubmed-meshheading:10094818...lld:pubmed
pubmed-article:10094818pubmed:meshHeadingpubmed-meshheading:10094818...lld:pubmed
pubmed-article:10094818pubmed:meshHeadingpubmed-meshheading:10094818...lld:pubmed
pubmed-article:10094818pubmed:meshHeadingpubmed-meshheading:10094818...lld:pubmed
pubmed-article:10094818pubmed:meshHeadingpubmed-meshheading:10094818...lld:pubmed
pubmed-article:10094818pubmed:meshHeadingpubmed-meshheading:10094818...lld:pubmed
pubmed-article:10094818pubmed:meshHeadingpubmed-meshheading:10094818...lld:pubmed
pubmed-article:10094818pubmed:meshHeadingpubmed-meshheading:10094818...lld:pubmed
pubmed-article:10094818pubmed:year1999lld:pubmed
pubmed-article:10094818pubmed:articleTitleAnalysis of site-specific phosphorylation of the retinoblastoma protein during cell cycle progression.lld:pubmed
pubmed-article:10094818pubmed:affiliationGenetics and Cancer Group, The Dupont Pharmaceuticals Company, Wilmington, Delaware, 19880, USA.lld:pubmed
pubmed-article:10094818pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10094818lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10094818lld:pubmed